Heart Asia uses an online submission and review system (Scholar One) and manuscripts must be submitted via Scholar One http://mc.manuscriptcentral.com/heartasia. You will need to register with Scholar One the first time you use the system.
BMJ Journals follows guidelines on editorial independence produced by the World Association of Medical Editors (www.wame.org/wamestmt.htm#independence), the code on good publication practice produced by the Committee on Publication Ethics (www.publicationethics.org.uk/guidelines/), and the EQUATOR network resource centre (http://www.equator-network.org/) for good research reporting.
In line with all BMJ Journals Heart Asia has stringent policies on authorship, ethics approval, patient consent, etc. These are explained in more detail on the Heart website.
Editors reserve the right to return manuscripts that do not meet these guidelines.
Authors (or their employers) retain their copyright in the article; the publishers require an exclusive licence (except for certain government employees who cannot grant this) that allows us to publish the article in Heart Asia (including any derivative products) and any other BMJ Publishing Group products, and allows us to sub-licence such rights and exploit all subsidiary rights.
We ask the corresponding author to grant this licence on behalf of all authors as shown in the Author Licence Form.
Authors can choose to have their article published Open Access for a fee of £1950 (plus applicable VAT).
We remind authors that currently the journal is freely available online at no charge. Please click here for information on how your paper will benefit from the Open Access service.
Heart Asia welcomes submissions for the following sections
- Original Research Articles
- Reviews, Viewpoints and Updates
Reviews of trends in cardiovascular disease relevant or peculiar to the Asian setting
- Controversies on Cardiovascular Medicine
Focusing on issues that are currently being debated and where there are opposing views.
- Reviews in Cardiovascular Technology
Reviews on technological developments in cardiovascular medicine and surgery.
- Updates in Cardiovascular Medicine
Articles focusing on a clinical condition, a diagnostic modality, therapeutic approaches or procedures.
- Practice Viewpoints
Articles providing practical advice relevant to current clinical practice.
- Expert Opinion
Articles addressing accepted practices in treatment paradigms where consensus is lacking or where there is conflicting evidence
- Healthcare policy
Articles on policy and guidelines relevant to the Asia Pacific region
- Images in Cardiovascular Medicine
Images that highlight new applications of a diagnostic or therapeutic procedure, or brief case studies that highlight a clinical application or interesting presentations of a clinical condition.
- Letters to the Editor
- Illustrations and additional material
Articles must be submitted online at http://mc.manuscriptcentral.com/heartasia
Authors submitting papers reporting original data (for example, controlled trials and intervention studies) should not exceed a limit of 3000 words, four figures and/or tables, and 30 references, and should provide a structured abstract of no more than 250 words. If after removing redundancy and repetition your article exceeds these limits please consider whether you are better served by writing two separate articles, but bear in mind the need to avoid duplicate publication. Reports of randomised controlled trials should follow the revised CONSORT statement (Consolidated Standards of Reporting Trials) published in JAMA (2001;285:1987-91) as closely as possible.
Authors submitting papers for these sections should not exceed 3000 words, four figures and/or tables, and 30 references, and should provide a brief summary of no more than 250 words.
Images that highlight new applications of a diagnostic or therapeutic procedure will be featured in this section as well
as brief case studies showing a clinical application or interesting presentation of a clinical condition. Articles should
not exceed 250 words, 2 illustrations and 2 references and there should be no more than 3 authors. Submissions that do not
adhere to these strict limits will be immediately returned to the author and not enter the peer review system. AVI or MPEG
files can be included as data supplements.
You need to provide proof of consent for publication from the patient(s) described in the article. We need written consent from every patient (or guardian) regardless of whether the patient can be identified from the images, preferably using the Heart Asia consent form.
Editorials are articles in which the author expresses an opinion on an aspect of cardiovascular medicine based on published data. They should not exceed 1500 words plus 16 references.
The editors of Heart Asia commission nearly all the editorials published in the journal. Before spontaneously sending us an editorial, please first consult us about your ideas. This will avoid the disappointment of finding that we have already commissioned an article on a similar topic from someone else.
Letters in response to articles published in Heart Asia are welcome and should be submitted electronically via the journal website. Contributors should go to the abstract or full text of the article in question. At the top right corner of each article is a "contents box". Click on the "eLetters: Submit a response to this article" link. Letters relating to or responding to previously published items in the journal will be shown to those authors, where appropriate. This is not available on the beta site.
Black and white images should be supplied as TIFF, GIF, EPS, PowerPoint or high quality JPEG files to a minimum of 300 dpi. Colour images should be supplied as TIFF, GIF, EPS, PowerPoint or high quality JPEG files to a minimum of 600 dpi.
Additional figures and tables, methodology, references, video clips, raw data etc, may be published online to supplement the article. If your paper exceeds the word count you should consider if any of the article could be published as a "data supplement". These files will not be copyedited or typeset.
Patient Consent Form
Please click here to download a copy of the patient consent form.
The BMJ Publishing Group journals are willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of:
- The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
- The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
- The BMJPG itself may have proposals for supplements where sponsorship may be necessary.
- A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.
In all cases, it is vital that the journal's integrity, independence and academic reputation is not compromised in any way.
When contacting us regarding a potential supplement, please include as much of the information below as possible.
- Journal in which you would like the supplement published
- Title of supplement and/or meeting on which it is based
- Date of meeting on which it is based
- Proposed table of contents with provisional article titles and proposed authors
- An indication of whether authors have agreed to participate
- Sponsor information including any relevant deadlines
- An indication of the expected length of each paper Guest Editor proposals if appropriate
For further information on criteria that must be fulfilled, download the supplements guidelines (PDF).
BMJ Group is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.
"The publication of a premier cardiology journal, Heart Asia, by BMJ Publishing Group is a significant step forwards as this will become the preferred journal of choice for many of the original research work in the Asia Pacific region,"
Professor Vinay K Bahl, All India Institute of Medical Sciences, New Delhi
"The launch of Heart Asia will provide doctors in China a platform to publish their original research data and it is an important bridge that will allow the Chinese cardiologists to integrate with the international cardiology community,"
Professor Hu Dayi, Chief of the Heart Centre at Peking Universityâ€™s Peopleâ€™s Hospital, Beijing
"Leading cardiology centres in the Asia Pacific region do some of the finest research in the world and the launch of Heart Asia is timely as it will allow top class research papers to be published in an Asia Pacific cardiology journal,"
Professor Ruey Jen Sung, Professor, Emeritus, Stanford University.